Literature DB >> 5960410

Mode of action of neocarzinostatin: inhibition of DNA synthesis and degradation of DNA in Sarcina lutea.

Y Ono, Y Watanabe, N Ishida.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5960410     DOI： 10.1016/0005-2787(66)90036-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN： 0006-3002


× No keyword cloud information.
  9 in total

1.  Nucleotide specificity in DNA scission by neocarzinostatin.

Authors:  T Hatayama; I H Goldberg; M Takeshita; A P Grollman
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

2.  Electron microscopic observations of neocarzinostatin treated Burkitt lymphoma cells.

Authors:  M Shamoto; Y Kawai; A Kato
Journal:  Experientia       Date:  1973-02-15

3.  Partial sequence of the tyrosine region of neocarzinostatin.

Authors:  C B Glaser; H Maeda; J Meienhofer; H D Niall
Journal:  Experientia       Date:  1972-07-15

4.  Biogenesis of an antitumor antibiotic protein, neocarzinostatin.

Authors:  K Kudo; M Kikuchi; N Ishida
Journal:  Antimicrob Agents Chemother       Date:  1972-04       Impact factor: 5.191

5.  Characterization of intracellular DNA strand breaks induced by neocarzinostatin in Escherichia coli cells.

Authors:  E Boye; W Köhnlein; K Skarstad
Journal:  Nucleic Acids Res       Date:  1984-11-12       Impact factor: 16.971

6.  Activation and inactivation of neocarzinostatin-induced cleavage of DNA.

Authors:  L S Kappen; I H Goldberg
Journal:  Nucleic Acids Res       Date:  1978-08       Impact factor: 16.971

7.  Mechanism of accumulation of the antitumor protein antibiotic neocarzinostatin in bladder tissue: intravenous administration, urinary excretion, and absorption into bladder tissue.

Authors:  H Maeda; S Sakamoto; J Ogata
Journal:  Antimicrob Agents Chemother       Date:  1977-06       Impact factor: 5.191

8.  Clinical pharmacology of the anticancer polypeptide neocarzinostatin.

Authors:  S W Hall; J Knight; A Broughton; R S Benjamin; E McKelvey
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

9.  A pharmacokinetic simulation model for chemotherapy of brain tumor with an antitumor protein antibiotic, neocarzinostatin. Theoretical considerations behind a two-compartment model for continuous infusion via an internal carotid artery.

Authors:  H Maeda; Y Sano; J Takeshita; Z Iwai; H Kosaka; T Marubayashi; Y Matsukado
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.